Guaifenesin And Pseudoephedrine Hcl Tablet, Extended Release
Product Images NDC 0536-1488

1 FDA label image from Rugby Laboratories, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Guaifenesin And Pseudoephedrine Hcl (NDC 0536-1488). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rugby Laboratories, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Rugby Guaifenesin 600mg Pse60mg 18ctcarton)

Carton (Rugby Guaifenesin 600mg Pse60mg 18ctcarton)
Carton label for Rugby brand mucus relief D extended-release tablets containing 600 mg guaifenesin and 60 mg pseudoephedrine HCl. The packaging states these 18 tablets serve as an expectorant and nasal decongestant with 12-hour relief. The label includes active ingredients, dosage form, uses, warnings, inactive ingredients, a tablet image, Drug Facts, barcodes, and contact information for Rugby Laboratories, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.